Dean Investment Associates’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
AI
Dean Investment Associates's HAE Position: Q2 2026 in Review
Dean Investment Associates opened a new position in Haemonetics (HAE) in Q2 2026: 61,989 shares worth $4.65M. The stake represents 0.61% of the portfolio and ranks #77 among its holdings. This is a return to the name: Dean Investment Associates previously reported a position in HAE as recently as Q2 2024.
Dean Investment Associates first reported a position in HAE in Q2 2014 and has held it in 16 quarters since. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Dean Investment Associates held 61,989 shares of Haemonetics worth $4.65M as of Q2 2026.
- Haemonetics was a new Dean Investment Associates position in Q2 2026.
- Haemonetics made up 0.61% of Dean Investment Associates's portfolio in Q2 2026, its #77 holding.
- Dean Investment Associates first reported a position in Haemonetics in Q2 2014 and has held it in 16 quarters since.
- 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Dean Investment Associates's 13F filing for Q2 2026, filed 14 Aug 2026.